Literature DB >> 28039356

Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue.

Eileen Snowden1, Warren Porter1, Friedrich Hahn1, Mitchell Ferguson1, Frances Tong1, Joel S Parker2,3, Aaron Middlebrook4, Smita Ghanekar4, W Shannon Dillmore1, Rainer Blaesius5.   

Abstract

Cancer tissue functions as an ecosystem of a diverse set of cells that interact in a complex tumor microenvironment. Genomic tools applied to biopsies in bulk fail to account for this tumor heterogeneity, whereas single-cell imaging methods limit the number of cells which can be assessed or are very resource intensive. The current study presents methods based on flow cytometric analysis and cell sorting using known cell surface markers (CXCR4/CD184, CD24, THY1/CD90) to identify and interrogate distinct groups of cells in triple-negative breast cancer clinical biopsy specimens from patient-derived xenograft (PDX) models. The results demonstrate that flow cytometric analysis allows a relevant subgrouping of cancer tissue and that sorting of these subgroups provides insights into cancer cell populations with unique, reproducible, and functionally divergent gene expression profiles. The discovery of a drug resistance signature implies that uncovering the functional interaction between these populations will lead to deeper understanding of cancer progression and drug response.Implications: PDX-derived human breast cancer tissue was investigated at the single-cell level, and cell subpopulations defined by surface markers were identified which suggest specific roles for distinct cellular compartments within a solid tumor. Mol Cancer Res; 15(4); 429-38. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28039356     DOI: 10.1158/1541-7786.MCR-16-0286-T

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  5 in total

1.  Synthetic Matrix Scaffolds Engineer the In Vivo Tumor Immune Microenvironment for Immunotherapy Screening.

Authors:  Meghan J O'Melia; Adriana Mulero-Russe; Jihoon Kim; Alyssa Pybus; Deborah DeRyckere; Levi Wood; Douglas K Graham; Edward Botchwey; Andrés J García; Susan N Thomas
Journal:  Adv Mater       Date:  2022-01-31       Impact factor: 30.849

Review 2.  Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models.

Authors:  William K Decker; Rodrigo F da Silva; Mayra H Sanabria; Laura S Angelo; Fernando Guimarães; Bryan M Burt; Farrah Kheradmand; Silke Paust
Journal:  Front Immunol       Date:  2017-08-02       Impact factor: 7.561

3.  Identification of Differentially Expressed Genes between Original Breast Cancer and Xenograft Using Machine Learning Algorithms.

Authors:  Deling Wang; Jia-Rui Li; Yu-Hang Zhang; Lei Chen; Tao Huang; Yu-Dong Cai
Journal:  Genes (Basel)       Date:  2018-03-12       Impact factor: 4.096

4.  Type-3 Hyaluronan Synthase Attenuates Tumor Cells Invasion in Human Mammary Parenchymal Tissues.

Authors:  Wen-Jui Lee; Shih-Hsin Tu; Tzu-Chun Cheng; Juo-Han Lin; Ming-Thau Sheu; Ching-Chuan Kuo; Chun A Changou; Chih-Hsiung Wu; Hui-Wen Chang; Hang-Lung Chang; Li-Ching Chen; Yuan-Soon Ho
Journal:  Molecules       Date:  2021-10-29       Impact factor: 4.411

5.  In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types.

Authors:  M D Matossian; T Chang; M K Wright; H E Burks; S Elliott; R A Sabol; H Wathieu; G O Windsor; M S Alzoubi; C T King; J B Bursavich; A M Ham; J J Savoie; K Nguyen; M Baddoo; E Flemington; O Sirenko; E F Cromwell; K L Hebert; F Lau; R Izadpanah; H Brown; S Sinha; J Zabaleta; A I Riker; K Moroz; L Miele; A H Zea; A Ochoa; B A Bunnell; B M Collins-Burow; E C Martin; M E Burow
Journal:  Clin Transl Oncol       Date:  2021-08-09       Impact factor: 3.405

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.